June 13, 2026
Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025 0
By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...
Read More Read more about Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation modernas-mrna-flu-vaccine-shows-superior-efficacy-navigates-fda-review-after-initial-hesitation

Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation

Ammar Sabilarrohman August 13, 2025 0
A groundbreaking Phase III trial has demonstrated that Moderna’s experimental mRNA-based flu vaccine, mRNA-1010, significantly outperforms a...
Read More Read more about Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation
Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities japan-faces-uphill-battle-to-achieve-lung-cancer-screening-goals-amidst-persistent-regional-and-gender-disparities

Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities

Raul Delapena Setiawan August 13, 2025 0
Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening...
Read More Read more about Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities
Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition funding-at-a-crossroads-metavivor-outlines-high-stakes-in-fy-2027-budget-battle-and-cdc-leadership-transition

Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

Nana Muazin August 11, 2025 0
WASHINGTON, D.C. — As the cherry blossoms reached their peak in the nation’s capital this April, the...
Read More Read more about Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

You may have missed

sensorion-abandons-otof-gene-therapy-program-a-strategic-pivot-amidst-shifting-market-realities

Sensorion Abandons OTOF Gene Therapy Program: A Strategic Pivot Amidst Shifting Market Realities

Nana Wu June 13, 2026
the-great-pivot-analyzing-the-trump-administrations-radical-overhaul-of-u-s-global-health-policy

The Great Pivot: Analyzing the Trump Administration’s Radical Overhaul of U.S. Global Health Policy

Ammar Sabilarrohman June 13, 2026
bridging-the-gap-in-metastatic-breast-cancer-advocacy-innovation-and-personal-triumph

Bridging the Gap in Metastatic Breast Cancer: Advocacy, Innovation, and Personal Triumph

Sagoh June 13, 2026
advocacy-in-focus-navigating-the-fiscal-year-2027-budget-and-public-health-leadership-shifts

Advocacy in Focus: Navigating the Fiscal Year 2027 Budget and Public Health Leadership Shifts

Muslim June 13, 2026